Zynerba Pharmaceuticals

$ZYNE is leading the Prism MarketView Cannabis Index and is up nearly 300% on news of its acquisition by Harmony Bio

Share this article:

About the Author:

Zynerba Pharmaceuticals

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup